Bollard Group LLC reports 8.94% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Bollard Group LLC
Latest Disclosed Ownership	115,000 shares
Latest Disclosed Value	$ 6,975

On May 14, 2026 - Bollard Group LLC filed a 13F-HR form disclosing ownership of 115,000 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $6,028,300 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 126,294 shares of Bristol-Myers Squibb Company. This represents a change in shares of -8.94% during the quarter. The current value of the position is $5,454,450 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	115,000	-11,294	-8.94	7	0.00	0.2055
2026-02-13	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	126,294	-7,511	-5.61	7	0.00	0.1702
2025-11-14	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	133,805	5,297	4.12	6	20.00	0.1418
2025-08-13	2025-06-30	13F	Bristol Myers Squibb	COM	110122108	128,508	7,811	6.47	6	-28.57	0.1360
2025-05-15	2025-03-31	13F	Bristol Myers Squibb	COM	110122108	120,697	1,019	0.85	7	16.67	0.1933
2025-02-14	2024-12-31	13F	Bristol Myers Squibb	COM	110122108	119,678	-935	-0.78	7	0.00	0.1876
2024-11-13	2024-09-30	13F	Bristol Myers Squibb	COM	110122108	120,613	-14,689	-10.86	6	20.00	0.1660
2024-08-14	2024-06-30	13F	Bristol Myers Squibb	COM	110122108	135,302	6,506	5.05	6	-16.67	0.1585
2024-05-13	2024-03-31	13F	Bristol Myers Squibb	COM	110122108	128,796	2,819	2.24	7	0.00	0.2113
2024-02-13	2023-12-31	13F	Bristol Myers Squibb	COM	110122108	125,977	-31,232	-19.87	6	-33.33	0.2248
2023-11-14	2023-09-30	13F	Bristol Myers Squibb	COM	110122108	157,209	-11,063	-6.57	9	-10.00	0.3358
2023-08-14	2023-06-30	13F	Bristol Myers Squibb	COM	110122108	168,272	1,184	0.71	11	-9.09	0.3661
2023-05-12	2023-03-31	13F	Bristol Myers Squibb	COM	110122108	167,088	887	0.53	12	0.00	0.4183
2023-02-10	2022-12-31	13F	Bristol Myers Squibb	COM	110122108	166,201	-7,884	-4.53	12	-99.91	0.4568
2022-11-09	2022-09-30	13F	Bristol Myers Squibb	COM	110122108	174,085	874	0.50	12,376	-7.21	0.5200
2022-08-12	2022-06-30	13F	Bristol Myers Squibb	COM	110122108	173,211	1,093	0.64	13,337	6.10	0.5405
2022-05-12	2022-03-31	13F	Bristol Myers Squibb	COM	110122108	172,118	11,747	7.32	12,570	25.71	0.4021
2022-02-11	2021-12-31	13F	Bristol Myers Squibb	COM	110122108	160,371	1,174	0.74	9,999	6.15	0.3201
2021-11-12	2021-09-30	13F	Bristol Myers Squibb	COM	110122108	159,197	8,246	5.46	9,420	-6.61	0.3086
2021-08-12	2021-06-30	13F	Bristol Myers Squibb	COM	110122108	150,951	11,117	7.95	10,087	14.26	0.3198
2021-05-11	2021-03-31	13F	Bristol Myers Squibb	COM	110122108	139,834	820	0.59	8,828	2.38	0.3093
2021-02-04	2020-12-31	13F	Bristol Myers Squibb	COM	110122108	139,014	783	0.57	8,623	3.47	0.3211
2020-11-12	2020-09-30	13F	Bristol Myers Squibb	COM	110122108	138,231	481	0.35	8,334	2.89	0.3003
2020-08-13	2020-06-30	13F	Bristol Myers Squibb	COM	110122108	137,750	2	0.00	8,100	5.50	0.3182
2020-05-14	2020-03-31	13F	Bristol Myers Squibb	COM	110122108	137,748	576	0.42	7,678	-12.80	0.3412
2020-02-10	2019-12-31	13F	Bristol Myers Squibb	COM	110122108	137,172	565	0.41	8,805	27.11	0.2858
2019-11-13	2019-09-30	13F	Bristol Myers Squibb	COM	110122108	136,607	-54,230	-28.42	6,927	-19.96	0.2433
2019-08-13	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	190,837	-57,508	-23.16	8,654	-26.96	0.2982
2019-05-10	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	248,345	27,745	12.58	11,849	3.33	0.4473
2019-02-05	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	220,600	10,858	5.18	11,467	-11.93	0.5057
2018-11-08	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	209,742	8,828	4.39	13,021	17.11	0.5235
2018-08-09	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	200,914	3,789	1.92	11,119	-10.82	0.5108
2018-05-14	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	197,125	6,771	3.56	12,468	6.88	0.6198
2018-01-29	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	190,354	-1,281	-0.67	11,665	-4.50	0.5608
2017-10-27	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	191,635	3,634	1.93	12,215	16.61	0.6440
2017-07-19	2017-06-30	13F	Bristol-Myers Squibb	COM	110122108	188,001	1,528	0.82	10,475	3.30	0.5657
2017-04-19	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	186,473	13,425	7.76	10,140	0.27	0.5814
2017-01-25	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	173,048	1,708	1.00	10,113	9.46	0.6596
2016-10-26	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	171,340	677	0.40	9,239	-26.39	0.5910
2016-07-20	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	170,663	715	0.42	12,552	15.62	0.8574
2016-05-09	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	169,948	825	0.49	10,856	-6.69	0.8742
2016-02-04	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	169,123	741	0.44	11,634	16.71	0.9577
2015-10-30	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	168,382	918	0.55	9,968	-10.54	0.8175
2015-08-12	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	167,464	934	0.56	11,143	3.74	0.8417
2015-05-12	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	166,530	4,590	2.83	10,741	12.37	0.7998
2015-02-12	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	161,940	7,056	4.56	9,559	20.59	0.8437
2014-11-14	2014-09-30	13F	Bristol-Myers Squibb	COM	110122108	154,884	8,415	5.75	7,927	11.57	0.7486
2014-08-13	2014-06-30	13F	Bristol-Myers Squibb	COM	110122108	146,469	2,489	1.73	7,105	-5.01	0.6865
2014-05-14	2014-03-31	13F	Bristol-Myers Squibb	COM	110122108	143,980	355	0.25	7,480	-2.02	0.7565
2014-02-13	2013-12-31	13F	Bristol-Myers Squibb	COM	110122108	143,625	3,538	2.53	7,634	17.75	0.8417
2013-11-12	2013-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	140,087	25,676	22.44	6,483	26.79	0.7625
2013-11-05	2013-09-30	13F	Bristol-Myers Squibb	COM	110122108	140,087			6,483
2013-08-12	2013-06-30	13F	Bristol-Myers Squibb	COM	110122108	114,411	114,411		5,113		0.9837

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.